The best discovery call feels like a consultation. The worst feels like a deposition.
If you leave discovery with a clean qualification grid and nothing else, you didn’t do discovery. You did intake. Real discovery is a clinical exercise — you’re diagnosing the customer’s situation, not qualifying their BANT.
This is the mindset shift that separates sellers who win competitive deals from those who don’t. Interrogators ask questions to extract data. Diagnosticians ask questions to build understanding — both for themselves and for the customer.
Three diagnostic moves I use on every discovery call:
1. Symptom → Mechanism
Don’t just catalog what the customer says is broken. Understand why it’s broken. The symptom is “our team can’t scale.” The mechanism might be “we have no system for onboarding the fifth hire after the founder stops being in every interview.” Those are entirely different problems, and only one of them is something you can actually solve.
In consulting, this was the difference between a BD call that earned a follow-up and one that earned a project. Symptom-level conversations got polite nods. Mechanism-level conversations got the customer to say “say more about that” — and that’s when real discovery starts.
2. Diagnosis → Prognosis
Once you understand the mechanism, help the customer see what happens if they don’t fix it. Not FUD — just consequence tracing. “If you keep onboarding this way, what happens when you hire three more?” “If the HL7 issue doesn’t get resolved before go-live, what does the first week of production look like?”
Medtech reps who could walk clinicians through the prognosis of not changing — the downstream clinical, operational, and financial costs — closed deals the competition couldn’t touch. Not because they were more aggressive. Because they were more useful.
The customer often hasn’t traced the consequences themselves. They see the symptom. They haven’t sat with what happens if it compounds for another two quarters. Helping them sit with it, calmly and clinically, is the most valuable thing you can do in a first meeting.
3. Prognosis → Urgency
Why now? This is the question that separates deals that close from deals that slip.
If the prognosis is bad but not urgent, the deal will slip indefinitely. If the prognosis is bad and there’s a forcing function — a contract expiry, a compliance deadline, a budget cycle, a competitor moving — the deal will close.
Good diagnosticians find the forcing function. Great ones help the customer see it when the customer didn’t. In telecom, the forcing function was often a build-out schedule. In construction, a bonding or insurance deadline. In medtech, a regulatory filing or a surgical volume ramp. In consulting, a board meeting or an earnings call. The forcing function is always there — it’s just rarely top of mind.
The way to tell whether you’re doing diagnostic discovery or interrogation discovery: count the ratio of qualifying questions to diagnostic questions in your recorded calls.
Qualifying questions sound like: “What’s your timeline?” “Who else is involved?” “What’s your budget?”
Diagnostic questions sound like: “Walk me through the last time this broke.” “What have you tried that didn’t work?” “If this stays broken, what breaks next?”
Healthy ratio is roughly 1 qualifying question per 3 diagnostic questions. Most reps run 3:1 the other direction — they front-load qualifying, which is why their discovery feels like intake.
The tactical benefit of diagnostic discovery is better data. The strategic benefit is that the customer leaves the call feeling like they understand their own situation better than before you showed up.
That’s trust. That’s why they take the next meeting. That’s why they refer you.
Audit one recorded discovery call this week. Count the ratios. If you’re interrogation-heavy, rewrite your opening five questions. You’ll see the difference in win rate within a quarter.